Clinical impact of two different intraoperative parathyroid hormone assays in primary and renal hyperparathyroidism

European Journal of Endocrinology

Volumn 160, Issue 2, 2009, Pages 275-281

  Meyer, Sonja Kerstin ^a   Zorn, Markus ^a   Frank Raue, Karin ^b   Büchler, Markus W ^a,c   Nawroth, Peter ^a   Weber, Theresia ^a,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Endokrinologische Gemeinschaftspraxis   (Germany)

^c Krankenhaus Salem   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CREATININE; PARATHYROID HORMONE;

ACCURACY; ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; HORMONE DETERMINATION; HUMAN; HYPOPARATHYROIDISM; IMMUNOASSAY; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QUANTITATIVE STUDY; RECURRENT LARYNGEAL NERVE PALSY; RENAL OSTEODYSTROPHY; AGED; BLOOD; CLINICAL CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; KIDNEY DISEASE; METHODOLOGY; MIDDLE AGED; PEROPERATIVE CARE; PREDICTION AND FORECASTING; REPRODUCIBILITY; SECONDARY HYPERPARATHYROIDISM; STANDARD; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; CHEMISTRY, CLINICAL; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; HYPERPARATHYROIDISM, SECONDARY; IMMUNOASSAY; INTRAOPERATIVE CARE; KIDNEY DISEASES; MALE; MIDDLE AGED; PARATHYROID HORMONE; PARATHYROIDECTOMY; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 61449249709     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0292     Document Type: Article

References (30)

1. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons. Position statement on the diagnosis and management of primary hyperparathyroidism. Endocrine Practice 2005 11 49-54.
2. Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Annals of Surgery 2002 235 665-670.
3. Bergenfelz A, Lindblom P, Tibblin S & Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Annals of Surgery 2002 236 543-551.
4. Grant CS, Thompson G, Farley D & van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Archives of Surgery 2005 140 472-479.
5. Miccoli P, Berti P, Materazzi G, Massi M, Picone A & Minuto MN. Results of video-assisted parathyroidectomy: single institution's six-year experience. World Journal of Surgery 2004 28 1216-1218.
6. Rothmund M, Wagner PK & Schark C. Subtotal parathyroidectomy versus total parathyroidectomy and autotransplantation in secondary hyperparathyroidism: a randomized trial. World Journal of Surgery 1991 15 745-750.
7. Kao PC, van Heerden JA, Grant CS, Klee GG & Kholsa S. Clinical performance of parathyroid hormone immunometric assays. Mayo Clinic Proceedings 1992 67 637-645.
8. Hruska KA, Korkor A, Martin K & Slatopolsky E. Peripheral metabolism of intact parathyroid hormone: role of liver and kidney and the effect of chronic renal failure. Journal of Clinical Investigation 1981 67 885-892.
9. Bergenfelz A, Norden NE & Ahren B. Intraoperative fall in plasma levels of intact parathyroid hormone after removal of one enlarged parathyroid gland in hyperparathyroid patients. European Journal of Surgery 1991 157 109-112.
10. Irvin GLIII, Dembrow VD & Prudhomme DL. Operative monitoring of parathyroid gland hyperfunction. American Journal of Surgery 1991 162 299-302.
11. Proye CA, Goropoulos A, Franz C, Carnaille B, Vix M, Quievreux JL, Couplet-Lebon G & Racadot A. Usefulness and limits of quick intraoperative measurements of intact (1-84) parathyroid hormone in the surgical management of hyperparathyroidism: sequential measurements in patients with multi-glandular disease. Surgery 1991 110 1035-1042.
12. Weber T, Zeier M, Hinz U, Schilling T & Buchler MW. Impact of parathyroid hormone levels on surgical results in patients with renal hyperparathyroidism. World Journal of Surgery 2005 29 1176-1179.
13. Bieglmayer C, Kaczirek K, Prager G & Niederle B. Parathyroid hormone monitoring during total parathyroidectomy for renal hyperparathyroidsm: pilot study of the impact of renal function and assay specificity. Clinical Chemistry 2006 52 1112-1119.
14. Holmes DT, Levin A, Forer B & Rosenberg F. Preanalytical influences on DPC Immulite 2000 intact PTH assays of plasma and serum from dialysis patients. Clinical Chemistry 2005 5 915-917.
15. Twomey PJ, Whitlock T & Pledger DR. Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice. Journal of Clinical Pathology 2005 58 1000-1001.
16. Amal L & Bergmann P. Evaluation of a chemiluminescence immunoassay for the determination of intact parathyroid hormone using the ADVIA Centaur. Clinical Laboratory 2004 50 695-702.
17. Carneiro-Pla DM, Solorzano CC & Irvin GL III. Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. Journal of the American College of Surgeons 2006 202 715-722.
18. Lepage R, Roy L, Brossard JH, Rousseau L, Dorais C, Lazure C & D'Amour P. A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples. Clinical Chemistry 1998 44 805-809.
19. Yamashita H, Gao P, Cantor T, Futata T, Murakami T, Uchino S, Watanabe S, Kawamoto H, Fukagawa M & Noguchi S. Large carboxy-terminal parathyroid hormone (PTH) fragment with a relatively longer half-life than 1-84 PTH is secreted directly from the parathyroid gland in humans. European Journal of Endocrinology 2003 149 301-306.
20. Lokey J, Pattou F, Mondragon-Sanchez A, Minuto M, Mullineris B, Wambergue F, Foissac-Geroux P, Noel C, de Sagazan HL, VanHille P & Proye CA. Intraoperative decay profile of intact (1-84) parathyroid hormone in surgery for renal hyperparathyroidism - a consecutive series of 80 patients. Surgery 2000 128 1029-1034.
21. Brossard JH, Cloutier M, Roy L, Lepage R, Gascon-Barre M & D'Amour P. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. Journal of Clinical Endocrinology and Metabolism 1996 81 3923-3929.
22. Seehofer D, Rayes N, Ulrich F, Muller C, Lang M, Neuhaus P & Steinmuller T. Intraoperative measurement of intact parathyroid hormone in renal hyperparathyroidism by an inexpensive routine assay. Langenbeck's Archives of Surgery 2001 386 440-443.
23. Haustein SV, Mack E, Starling JR & Chen H. The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation. Surgery 2005 138 1066-1071.
24. Johnson LR, Doherty G, Lairmore T, Moley JF, Brunt LM, Koenig J & Scott MG. Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy. Clinical Chemistry 2001 47 919-925.
25. Hermse D, Franzson L, Hoffmann JP, Isaksson A, Kaufman JM, Leary E, Muller C, Nakatsuka K, Nishizawa Y, Reinauer H, Riesen W, Roth HJ, Steinmuller T, Troch T & Bergmann P. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010. Clinical Laboratory 2002 48 131-141.
26. Yamashita H, Gao P, Cantor T, Noguchi S, Uchino S, Watanabe S, Ogawa T, Kawamoto H & Fukagawa M. Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism. Surgery 2004 135 149-156.
27. Worth GK, Vasikaran SD, Retallack RW, Musk AA & Gutteridge DH. Major method-specific differences in the measurement of intact parathyroid hormone: studies in patients with and without chronic renal failure. Annals of Clinical Biochemistry 2004 41 149-154.
28. Kao PC, van Heerden JA, Farley DR, Thompson GB & Taylor RL. Intraoperative monitoring of parathyroid hormone with a rapid automated assay that is commercially available. Annals of Clinical and Laboratory Science 2002 32 244-251.
29. Westerdahl J & Bergenfelz A. Sestamibi scan-directed parathyroid surgery: potentially high failure rate without measurement of intraoperative parathyroid hormone. World Journal of Surgery 2004 28 1132-1138.
30. Souberbielle J-C, Boutten A, Carlier M-C, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E & Houillier P. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney International 2006 70 345-350.